QT Vascular gets US nod on four key patents
Add BT as a preferred sourceSingapore
MEDICAL supplies group QT Vascular said the United States Patent and Trademark Office has issued allowance letters of four fundamental patents that are key to its portfolio of specialty balloons for the treatment of vascular disease in coronary and peripheral vessels.
The Catalist-listed firm on Wednesday said three of the patents cover the group's flagship platform, Chocolate®, while the fourth covers its Glider™ family of products.
TRENDING NOW
DBS COO’s most important tip for AI transformation: Lead with ‘why’
Vietnam seeks US$76 billion a year from capital markets to ease reliance on banks
Too little, too late? Manila’s billion-dollar bid to ignite its sputtering EV industry
Two-thirds of Sentosa Cove resales in the red, with average loss topping S$1 million since 2023
